Review Article
Novel Biomarkers for Alzheimer’s Disease: Plasma Neurofilament Light and Cerebrospinal Fluid
Table 1
Molecules that showed differential levels in CSF from Alzheimer’s disease patients as compared to controls.
| | Protein | Up/downregulated |
| | Albumin | ↑ | | Amyloid β A4 protein | ↑ | | Apolipoprotein AI | ↑ | | Apolipoprotein AII | ↑ | | Apolipoprotein E | ↑ | | BACE 1 | ↑ | | 24S-Hydroxycholesterol | ↑ | | C3a | ↑ | | C4a | ↑ | | Cystatin C | ↑ | | Cystatin C, 8 amino acid N-terminal truncation | ↑ | | Immunoglobulin heavy chain | ↓ | | Leucine-rich repeat-containing protein 4B | ↑ | | Leucine-rich repeat-containing protein 4B | ↓ | | N-acetyllactosamine | ↓ | | Neuronal pentraxin-1 | ↑ | | Prostaglandin-H2 D-isomerase | ↑ ↓ | | Retinol-binding protein | ↑ | | Thioredoxin | ↑ | | Transthyretin | ↓ ↑ ↓ | | VGF | ↑ | | a-1-Antitrypsin | ↑ | | α-1β glycoprotein | ↑ | | α-2HS glycoprotein | ↓ | | β fibrinogen | ↑ | | β-2-Microglobulin | ↓ |
|
|